Personalizing and targeting therapy for COPD–the role of molecular and clinical biomarkers

F Goh, JG Shaw, SM Savarimuthu Francis… - Expert Review of …, 2013 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized
by persistent airflow limitation. It is the third leading cause of death worldwide, and there are …
被引用次数：20 相关文章

Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers.

F Goh, JG Shaw, SF SM, A Vaughan… - Expert Review of …, 2013 - europepmc.org
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized
by persistent airflow limitation. It is the third leading cause of death worldwide, and there are …

Personalizing and targeting therapy for COPD-the role of molecular and clinical biomarkers

F Goh, JG Shaw, SMS Francis… - Expert Review of …, 2013 - search.proquest.com
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized
by persistent airflow limitation. It is the third leading cause of death worldwide, and there are …

Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers

F Goh, JG Shaw, SMS Francis… - Expert review of …, 2013 - pubmed.ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized
by persistent airflow limitation. It is the third leading cause of death worldwide, and there are …

[引用][C] Personalizing and targeting therapy for COPD-The role of molecular and clinical biomarkers

F Goh, JG Shaw, FSM Savarimuthu… - Expert Review of …, 2013 - espace.library.uq.edu.au
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized
by persistent airflow limitation. It is the third leading cause of death worldwide, and there are …